Copyright
©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5524-5531
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5524
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5524
Table 2 Mean ± SD change in hepatitis B virus DNA levels from baseline (log10 copies/mL)
| Weeks from baseline | HBeAg-negative | HBeAg-positive | ||
| Asians | Non-Asian | Asians | Non-Asian | |
| n = 102 | n = 186 | n = 115 | n = 113 | |
| Week 4 | -2.9 ± 0.82 | -2.9 ± 0.80 | -3.1 ± 0.76 | -2.9 ± 0.77 |
| Week 8 | -3.4 ± 1.04 | -3.5 ± 0.85 | -4.0 ± 1.07 | -3.8 ± 0.88 |
- Citation: Pan CQ, Chan S, Trinh H, Yao A, Bae H, Lou L. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B. World J Gastroenterol 2015; 21(18): 5524-5531
- URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5524.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5524